Monday, May 16, 2022
Distribution: (800) 510 0384
Washington DC
New York
Toronto
Press ID  
  • Login
The Hudson Weekly
  • Financial
  • Blockchain
  • Technology
  • Entertainment
  • Lifestyle
  • Arts
  • Health
  • Sports
  • Cybersecurity
No Result
View All Result
  • Financial
  • Blockchain
  • Technology
  • Entertainment
  • Lifestyle
  • Arts
  • Health
  • Sports
  • Cybersecurity
No Result
View All Result
The Hudson Weekly
No Result
View All Result

FDA Approves Treatment for Chronic Kidney Disease

Approval is First to Cover Many Causes of Disease

Craig Richer by Craig Richer
May 3, 2021
in Health
A A
FDA Accepts BioMarin’s New Drug Application for Vosoritide to Treat Children with Achondroplasia

© FDA

Share on FacebookShare on Twitter

U.S. Food and Drug Administration approved Farxiga (dapagliflozin) oral tablets to reduce the risk of kidney function decline, kidney failure, cardiovascular death and hospitalization for heart failure in adults with chronic kidney disease who are at risk of disease progression.

“Chronic kidney disease is an important public health issue, and there is a significant unmet need for therapies that slow disease progression and improve outcomes,” said Aliza Thompson, M.D., M.S., deputy director of the Division of Cardiology and Nephrology in the FDA’s Center for Drug Evaluation and Research. “Today’s approval of Farxiga for the treatment of chronic kidney disease is an important step forward in helping people living with kidney disease.”

HudsonNewsroom

Antoine Skaff and His American Success Story (Exclusive Interview)

The Future of Stroke Care in the US and Canada: An Interview With Dr. Atif Zafar

Meet Successful Black Woman Nominated for Forbes Next 1000 Honoree That Owns 14 Healthcare Franchise Locations Around the USA

Chronic kidney disease occurs when the kidneys are damaged and cannot filter blood normally. Due to this defective filtering, patients can have complications related to fluid, electrolytes (minerals required for many bodily processes), and waste build-up in the body. Chronic kidney disease sometimes can progress to kidney failure. Patients also are at high risk of cardiovascular disease, including heart disease and stroke.

The efficacy of Farxiga to improve kidney outcomes and reduce cardiovascular death in patients with chronic kidney disease was evaluated in a multicenter, double-blind study. In this study, 4,304 patients were randomly assigned to receive either Farxiga or a placebo. The study compared the two groups for the number of patients whose disease progressed to a composite (or combined) endpoint that included at least a 50% reduction in kidney function, progression to kidney failure, or cardiovascular or kidney death. Results showed that 197 of the 2,152 patients who received Farxiga had at least one of the composite endpoint events compared to 312 of the 2,152 patients who received a placebo. The study also compared the two groups for the number of patients who were hospitalized for heart failure or died from cardiovascular disease. A total of 100 patients who received Farxiga were hospitalized or died compared to 138 patients who received a placebo.

Farxiga was not studied, nor is expected to be effective, in treating chronic kidney disease among patients with autosomal dominant or recessive polycystic (characterized by multiple cysts) kidney disease or among patients who require or have recently used immunosuppressive therapy to treat kidney disease.

Patients should not use Farxiga if they have a history of serious hypersensitivity reactions to the medication or if they are on dialysis treatment. Serious, life-threatening cases of Fournier’s Gangrene have occurred in patients with diabetes taking Farxiga. Patients should consider a lower dose of insulin or insulin secretagogue to reduce the risk of hypoglycemia (low blood sugar) if they are also taking Farxiga. Farxiga can cause dehydration, serious urinary tract infections, genital yeast infections, and metabolic acidosis or ketoacidosis (acid build-up in the blood). Patients should be assessed for their volume status and kidney function before starting Farxiga.

Farxiga was originally approved in 2014 to improve glycemic control in adults with type 2 diabetes in addition to diet and exercise.

Farxiga received Fast Track, Breakthrough Therapy, and Priority Review designations for the indication being approved today. Fast track is designed to facilitate the development and expedite the review of drugs to treat serious conditions and fill an unmet medical need. Breakthrough therapy designation is designed to expedite the development and review of drugs that are intended to treat a serious condition and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over available therapy on a clinically significant endpoint(s). Priority review directs overall attention and resources to the evaluation of applications for drugs that, if approved, would be significant improvements in the safety or effectiveness of the treatment, diagnosis or prevention of serious conditions when compared to standard applications.

The FDA granted the approval of Farxiga to AstraZeneca.

Craig Richer

Craig Richer

Newsroom Editor

More from HW Newsdesk

Antoine Skaff and His American Success Story (Exclusive Interview)
Health

Antoine Skaff and His American Success Story (Exclusive Interview)

May 12, 2022
The Future of Stroke Care in the US and Canada: An Interview With Dr. Atif Zafar
Health

The Future of Stroke Care in the US and Canada: An Interview With Dr. Atif Zafar

May 1, 2022
Meet Black Woman Nominated for Forbes Next 1000 Honoree That Owns 14 Healthcare Franchise Locations Around the USA
Health

Meet Successful Black Woman Nominated for Forbes Next 1000 Honoree That Owns 14 Healthcare Franchise Locations Around the USA

May 2, 2022

HW Newsroom

Kevin Hoover: One of the Most Prominent 5-Star Recruits
Sports

Kevin Hoover: One of the Most Prominent 5-Star Recruits

by Matthew Kushner
May 14, 2022

Kevin Hoover (2018), 6'1 wing, Beacon High School (4.0 GPA) Hoover has exceptional guard skills for his size and can...

Fusiotech India Spreading Its Operation Globally

Fusiotech India Spreading Its Operation Globally

May 14, 2022
Ferrinis: Two Brothers in Music

Ferrinis: Two Brothers in Music

May 13, 2022
The Talent Artist Annie Chen Ziyao Presents Her Latest Project Ms. Meta Meta to the Public

The Talent Artist Annie Chen Ziyao Presents Her Latest Project Ms. Meta Meta to the Public

May 13, 2022
Peter Lake Releases His 2nd EP Year-to-Date Entitled 'Black&White'

Peter Lake Releases His 2nd EP Year-to-Date Entitled ‘Black&White’

May 12, 2022
Flying Scotsman's US Appeal Ahead of Historic Centenary

Flying Scotsman’s US Appeal Ahead of Historic Centenary

May 12, 2022
CounterCraft Launches The Service™ to Provide Deception-Powered Threat Intel

CounterCraft Launches The Service™ to Provide Deception-Powered Threat Intel

May 12, 2022
Antoine Skaff and His American Success Story (Exclusive Interview)

Antoine Skaff and His American Success Story (Exclusive Interview)

May 12, 2022
TWO Inc.'s Japanese Plant-Based Food Brand 2Foods Received the Enterprise Award at the 2022 Vegan Awards

TWO Inc.’s Japanese Plant-Based Food Brand 2Foods Received the Enterprise Award at the 2022 Vegan Awards

May 11, 2022
GA-ASI Grows Mojave Line With New MQ-9B STOL Package

GA-ASI Grows Mojave Line With New MQ-9B STOL Package

May 10, 2022
SHARE Texas Trees Foundation Celebrates the Completion of Seven Neighborhood Parks at Dallas ISD Schools

SHARE Texas Trees Foundation Celebrates the Completion of Seven Neighborhood Parks at Dallas ISD Schools

May 10, 2022
The Storage Acquisition Group Closes New Hampshire Facility

The Storage Acquisition Group Closes New Hampshire Facility

May 10, 2022
No Result
View All Result

Headlines

$3.925 Million Golf-Front Estate is Highest-Priced Sale in The History Of Treviso Bay

The FieldTurf Legend Continues at the University of Nebraska

Enstrom Helicopter Under New and Stable Ownership

Kevin Hoover: One of the Most Prominent 5-Star Recruits

Fusiotech India Spreading Its Operation Globally

Ferrinis: Two Brothers in Music

Trending

That Witch Beauty and Kitsie Duncan’s Inspiration Behind Her Anti-Aging, Self Care Beauty Brand
Lifestyle

That Witch Beauty and Kitsie Duncan’s Inspiration Behind Her Anti-Aging, Self Care Beauty Brand

by Craig Richer
May 14, 2022

A new self care beauty brand by Kitsie Duncan has launched online. Called That Witch Beauty, with...

Surgical Steel Earrings: Safe Anti-Allergy Material

Surgical Steel Earrings: Safe Anti-Allergy Material

May 14, 2022
$3.925 Million Golf-Front Estate is Highest-Priced Sale in The History Of Treviso Bay

$3.925 Million Golf-Front Estate is Highest-Priced Sale in The History Of Treviso Bay

May 14, 2022
The FieldTurf Legend Continues at the University of Nebraska

The FieldTurf Legend Continues at the University of Nebraska

May 14, 2022
Enstrom Helicopter Under New and Stable Ownership

Enstrom Helicopter Under New and Stable Ownership

May 14, 2022
  • Statement by U.S. Conference of Mayors on Mass Shooting in Buffalo

https://ritzherald.com/statement-by-u-s-conference-of-mayors-on-mass-shooting-in-buffalo/

#nyc #losangeles #chicago #houston #phoenix #philadelphia #sandiego #dallas #sanfrancisco #seattle #denver #washingtondc #boston #detroit #vancouver #toronto #publicrelations #marketingagency #earnedmedia #editorial #marketing #marketingstrategy #marketingdigital #guestpost #guestposting #marketingtips #pr
  • Sea Ice Can Control Antarctic Ice Sheet Stability, New Research Finds

https://ritzherald.com/sea-ice-can-control-antarctic-ice-sheet-stability-new-research-finds/

#nyc #losangeles #chicago #houston #phoenix #philadelphia #sandiego #dallas #sanfrancisco #seattle #denver #washingtondc #boston #detroit #vancouver #toronto #publicrelations #marketingagency #earnedmedia #editorial #marketing #marketingstrategy #marketingdigital #guestpost #guestposting #marketingtips #pr #sealevelrise
  • USW Announces Tentative Agreement With Arconic on Four-Year Contract

https://ritzherald.com/usw-announces-tentative-agreement-with-arconic-on-four-year-contract/

#nyc #losangeles #chicago #houston #phoenix #philadelphia #sandiego #dallas #sanfrancisco #seattle #denver #washingtondc #boston #detroit #vancouver #toronto #publicrelations #marketingagency #earnedmedia #editorial #marketing #marketingstrategy #marketingdigital #guestpost #guestposting #marketingtips #pr
  • MOZAIK Philanthropy Announces Open Call for Digital Art

https://ritzherald.com/mozaik-philanthropy-announces-open-call-for-digital-art/

#nyc #losangeles #chicago #houston #phoenix #philadelphia #sandiego #dallas #sanfrancisco #seattle #denver #washingtondc #boston #detroit #vancouver #toronto #publicrelations #marketingagency #earnedmedia #editorial #marketing #marketingstrategy #marketingdigital #guestpost #guestposting #marketingtips #pr #digitalartist
  • Southwestern Association for Indian Arts Announces Centennial Fashion Designers

https://ritzherald.com/southwestern-association-for-indian-arts-announces-centennial-fashion-designers/

#nyc #losangeles #chicago #houston #phoenix #philadelphia #sandiego #dallas #sanfrancisco #seattle #denver #washingtondc #boston #detroit #vancouver #toronto #publicrelations #marketingagency #earnedmedia #editorial #marketing #marketingstrategy #marketingdigital #guestpost #guestposting #marketingtips #pr
  • Unreleased Live Concert of Ella Fitzgerald Performing Songs From Her Beloved Irving Berlin Songbook

https://ritzherald.com/unreleased-live-concert-of-ella-fitzgerald-performing-songs-from-her-beloved-irving-berlin-songbook/

#nyc #losangeles #chicago #houston #phoenix #philadelphia #sandiego #dallas #sanfrancisco #seattle #denver #washingtondc #boston #detroit #vancouver #toronto #publicrelations #marketingagency #earnedmedia #editorial #marketing #marketingstrategy #marketingdigital #guestpost #guestposting #marketingtips #pr #ellafitzgerald
  • Cedars-Sinai Leader in Maternal-Fetal Medicine Honored for Dedication to Women’s Healthcare

https://ritzherald.com/cedars-sinai-leader-in-maternal-fetal-medicine-honored-for-dedication-to-womens-healthcare/

#nyc #losangeles #chicago #houston #phoenix #philadelphia #sandiego #dallas #sanfrancisco #seattle #denver #washingtondc #boston #detroit #vancouver #toronto #publicrelations #marketingagency #earnedmedia #editorial #marketing #marketingstrategy #marketingdigital #guestpost #guestposting #marketingtips #pr
  • IAPMO Supports U.S. Sen. Tammy Baldwin’s Healthy Drinking Water Affordability Act

https://ritzherald.com/iapmo-supports-u-s-sen-tammy-baldwins-healthy-drinking-water-affordability-act/

#nyc #losangeles #chicago #houston #phoenix #philadelphia #sandiego #dallas #sanfrancisco #seattle #denver #washingtondc #boston #detroit #vancouver #toronto #publicrelations #marketingagency #earnedmedia #editorial #marketing #marketingstrategy #marketingdigital #guestpost #guestposting #marketingtips #pr

© 2022 The Hudson Weekly. Published by The Ritz Herald. Editions: Markets Herald • Lincoln Citizen • Madison Graph • Belmont Star • Fairmont Post

Address: 1177 6th Avenue, 5th Floor, New York, NY 10036. Contact: pr@hudsonweekly.com. Phone: (718) 313-5252. M-F: 9AM-5PM. Privacy Policy

No Result
View All Result
  • Financial
  • Blockchain
  • Technology
  • Entertainment
  • Lifestyle
  • Arts
  • Health
  • Sports
  • Cybersecurity

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist